CD274 and neoplasm: Consistent with this, treatment of cells with ROS-inducing agents, such as buthionine sulfoximine and paclitaxel, has been shown to increase the expression of PD-L1 on the surface of tumor-associated macrophages, subsequently promoting tumor growth [22].